Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||||
| Cash income from operating activities | -7.68%4.01M | 488.64%4.34M | -91.12%736.99K | 349.54%8.3M | 1.85M | -2.46M | |
| Revenue from customers | -7.07%4.03M | 558.89%4.34M | -92.02%658.41K | --8.25M | ---- | ---- | ---2.46M |
| Other cash income from operating activities | ---26.45K | ---- | 67.55%78.58K | -97.46%46.9K | --1.85M | ---- | ---- |
| Cash paid | 7.28%-6.22M | 7.42%-6.71M | -51.56%-7.25M | -38.46%-4.78M | 1.38%-3.45M | -42.24%-3.5M | -2.46M |
| Payments to suppliers for goods and services | 7.28%-6.22M | 7.42%-6.71M | -51.56%-7.25M | -41.34%-4.78M | 1.87%-3.38M | -40.04%-3.45M | ---2.46M |
| Other cash payments from operating activities | ---- | ---- | ---- | ---- | -29.85%-70.38K | ---54.2K | ---- |
| Direct interest paid | 25.41%-822.74K | 0.54%-1.1M | ---1.11M | ---- | ---- | ---- | ---- |
| Direct interest received | -35.55%34.24K | -57.31%53.12K | 12,149.51%124.46K | -70.38%1.02K | -97.54%3.43K | --139.21K | ---- |
| Operating cash flow | 12.18%-3M | 54.36%-3.42M | -313.07%-7.49M | 319.27%3.52M | 52.29%-1.6M | -36.58%-3.36M | ---2.46M |
| Investing cash flow | |||||||
| Cash flow from continuing investing activities | -12.51%-3.57M | 63.37%-3.17M | 32.45%-8.67M | -46.92%-12.83M | 51.51%-8.73M | -117.24%-18.01M | -8.29M |
| Capital expenditure reported | -12.92%-3.57M | 62.57%-3.16M | 34.01%-8.45M | -47.20%-12.81M | 51.69%-8.7M | -120.52%-18.01M | ---8.17M |
| Net PPE purchase and sale | ---- | 94.68%-11.53K | -758.17%-216.75K | 25.77%-25.26K | -886.23%-34.03K | 97.24%-3.45K | ---124.9K |
| Cash from discontinued investing activities | |||||||
| Investing cash flow | -12.51%-3.57M | 63.37%-3.17M | 32.45%-8.67M | -46.92%-12.83M | 51.51%-8.73M | -117.24%-18.01M | ---8.29M |
| Financing cash flow | |||||||
| Cash flow from continuing financing activities | -83.83%1.15M | 43.33%7.1M | -76.00%4.96M | 44.83%20.66M | 466.07%14.26M | -91.03%2.52M | 28.1M |
| Net issuance payments of debt | ---- | ---- | ---- | --10M | ---- | ---- | ---- |
| Net common stock issuance | -82.28%1.3M | 41.22%7.32M | -54.40%5.19M | -21.24%11.37M | 445.43%14.44M | -90.58%2.65M | --28.1M |
| Net other financing activities | 31.91%-148.92K | 4.47%-218.72K | 67.98%-228.96K | -305.47%-715.06K | -38.13%-176.35K | ---127.68K | ---- |
| Cash from discontinued financing activities | |||||||
| Financing cash flow | -83.83%1.15M | 43.33%7.1M | -76.00%4.96M | 44.83%20.66M | 466.07%14.26M | -91.03%2.52M | --28.1M |
| Net cash flow | |||||||
| Beginning cash position | 6.79%8.02M | -59.88%7.51M | 153.93%18.71M | 114.01%7.37M | -84.56%3.44M | 350.36%22.3M | --4.95M |
| Current changes in cash | -1,163.93%-5.43M | 104.55%510.04K | -198.78%-11.2M | 188.93%11.34M | 120.82%3.93M | -208.69%-18.85M | --17.35M |
| End cash Position | -67.68%2.59M | 6.79%8.02M | -59.88%7.51M | 153.93%18.71M | 114.01%7.37M | -84.56%3.44M | --22.3M |
| Free cash from | 0.29%-6.58M | 59.19%-6.59M | -73.51%-16.16M | 9.90%-9.31M | 51.63%-10.34M | -98.77%-21.37M | ---10.75M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |